Results 141 to 150 of about 30,153 (204)

Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial. [PDF]

JCO Precis Oncol
Agrawal YN, Fernández-Martínez A, Gil-Gil M, Zielinski C, Ruiz-Borrego M, Ciruelos EM, Muñoz M, Margelí M, Bermejo B, Antón A, Kahan Z, Csöszi T, Alonso-Romero JL, García-Saenz JÁ, Sánchez-Rovira P, Álvarez E, Chacón JI, González-Santiago S, Rodríguez CA, Servitja S, Pfefferle AD, Herranz J, Liu Y, Carey LA, Romero-Camarero I, Caballero R, Guerrero-Zotano Á, Perou CM, Martín M.   +28 more
europepmc   +1 more source

Real-world progression-free survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR-positive/HER2-negative metastatic breast cancer in United States routine clinical practice. [PDF]

ESMO Open
Rugo HS, Layman RM, Lynce F, Liu X, Li B, McRoy L, Cohen AB, Estevez M, Curigliano G, Brufsky A.   +9 more
europepmc   +1 more source

Response to the letter Re: Comparative overall survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2- metastatic breast cancer in the US real-world setting. [PDF]

ESMO Open
Rugo HS, Layman RM, Lynce F, Liu X, Li B, McRoy L, Cohen AB, Estevez M, Curigliano G, Brufsky A.   +9 more
europepmc   +1 more source

Correction to: "Adult Height Following Prepubertal Treatment With Antiandrogen, Aromatase Inhibitor, and Reduced Hydrocortisone in CAH".

J Clin Endocrinol Metab
europepmc   +1 more source

Current and future advances in practice: aromatase inhibitor-induced arthralgia. [PDF]

Rheumatol Adv Pract
Kim S, Chen N, Reid P.
europepmc   +1 more source

Preclinical Efficacy of the Estrogen Receptor Degrader Fulvestrant in Combination with RAF/MEK Clamp Avutometinib and FAK Inhibitor in a Low-Grade Serous Ovarian Cancer Animal Model with Acquired Resistance to Chemotherapy and Aromatase Inhibitor. [PDF]

Int J Mol Sci
Demirkiran C, Bellone S, Ettorre VM, Mansolf M, Hartwich TMP, McNamara B, Greenman M, Yang-Hartwich Y, Ratner E, Santin NG, Sethi N, Palmieri L, Coma S, Pachter JA, Ottum S, Santin AD.   +15 more
europepmc   +1 more source

Reproductive changes in male rats treated perinatally with an aromatase inhibitor

Pharmacology Biochemistry and Behavior, 2002
The effects of maternal exposure to aromatase inhibitor during the perinatal period of sexual brain differentiation were studied. The fertility was assessed in adult, male rat offspring of aromatase inhibitor-treated dams.
Oduvaldo C M Pereira
exaly   +3 more sources